启动免疫球蛋白替代疗法有助于减少美国先天性免疫缺陷患者的严重感染并将医疗资源利用转向门诊服务

美国先天性免疫缺陷患者启动免疫球蛋白疗法后的医疗资源利用和费用变化回顾性分析数据集。

Taylor & FrancisTaylor & Francis
DataCite Commons
2026-03-17 更新
浏览 12
表格Inborn errors of immunityimmunoglobulin replacement therapyhealthcare resource utilizationCOVID-19infection ratesI10I1II15
Initiating immunoglobulin replacement therapy helps reduce severe infections and shifts healthcare resource utilization to outpatient services among US patients with inborn errors of immunity

基本信息

模态
表格
大小
0.003313648 GB
许可
CC BY 4.0
创建/更新时间
2026-03-17
版本
v3

资源简介

启动免疫球蛋白替代疗法有助于减少美国先天性免疫缺陷患者的严重感染并将医疗资源利用转向门诊服务

【一句话概览】

本数据集是 figshare 公开的结构化表格数据集,收录 8 个文件、合计 3.31 MB,主题涵盖 Inborn errors of immunity、immunoglobulin replacement therapy、healthcare resource utilization、COVID-19、infection rates,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Initiating immunoglobulin replacement therapy helps reduce severe infections and shifts healthcare resource utilization to outpatient services among US patients with inborn errors of immunity》。配套论文《Initiating immunoglobulin replacement therapy helps reduce severe infections and shifts healthcare resource utilization to outpatient services among US patients with inborn errors of immunity》发表于 Journal of Medical Economics(2024),DOI:10.1080/13696998.2024.2368987。源站首次发布:2024-08-13。

【数据内容】

源站原始描述:Patients with inborn errors of immunity (IEI) are predisposed to severe recurrent/chronic infections, and often require hospitalization, resulting in substantial burden to patients/healthcare systems. While immunoglobulin replacement therapies (IgRTs) are the standard first-line treatment for most forms of IEI, limited real-world data exist regarding clinical characteristics and treatment costs for patients with IEI initiating such treatment. This retrospective analysis examined infection and tr…

【数据结构与技术规格】

文件数 8 个,合计 3.31 MB。ijme_a_2368987_sm1178.eps:image/x-eps,770.15 KB。ijme_a_2368987_sm1172.eps:image/x-eps,795.43 KB。ijme_a_2368987_sm1158.jpg:image/jpeg,123.25 KB。数据集 DOI:10.6084/m9.figshare.26049805.v3。

【主题与分类】

源站学科分类:Medicine、Microbiology、Pharmacology、Immunology、Cancer、Mental Health。主题标签:Inborn errors of immunity、immunoglobulin replacement therapy、healthcare resource utilization、COVID-19、infection rates、I10、I1、I、I15。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://tandf.figshare.com/articles/dataset/Initiating_immunoglobulin_replacement_therapy_helps_reduce_severe_infections_and_shifts_healthcare_resource_utilization_to_outpatient_services_among_US_patients_with_inborn_errors_of_immunity/26049805

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Initiating immunoglobulin replacement therapy helps reduce severe infections and shifts healthcare resource utilization to outpatient services among US patients with inborn errors of immunity. Taylor & Francis. Riaz, Faisal; Umashankar, Kandavadivu; Marchlewicz, Elizabeth Hoit; Zhang, Kui; Khandelwa…

【使用注意】

· 源站最后修改于 2026-03-17,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "ijme_a_2368987_sm1178.eps" "https://ndownloader.figshare.com/files/48403705"
curl -L -o "ijme_a_2368987_sm1172.eps" "https://ndownloader.figshare.com/files/48403708"
curl -L -o "ijme_a_2368987_sm1158.jpg" "https://ndownloader.figshare.com/files/48403714"
curl -L -o "ijme_a_2368987_sm1157.jpg" "https://ndownloader.figshare.com/files/48403717"
curl -L -o "ijme_a_2368987_sm1146.eps" "https://ndownloader.figshare.com/files/48403723"
curl -L -o "ijme_a_2368987_sm1145.eps" "https://ndownloader.figshare.com/files/48403726"
curl -L -o "ijme_a_2368987_sm1144.eps" "https://ndownloader.figshare.com/files/48403729"
curl -L -o "ijme_a_2368987_sm1065.docx" "https://ndownloader.figshare.com/files/48403732"

文件清单

  • ijme_a_2368987_sm1178.eps(770.15 KB)
  • ijme_a_2368987_sm1172.eps(795.43 KB)
  • ijme_a_2368987_sm1158.jpg(123.25 KB)
  • ijme_a_2368987_sm1157.jpg(99.36 KB)
  • ijme_a_2368987_sm1146.eps(485.37 KB)
  • ijme_a_2368987_sm1145.eps(377.93 KB)
  • ijme_a_2368987_sm1144.eps(588.36 KB)
  • ijme_a_2368987_sm1065.docx(73.81 KB)

文件总体积 3.31 MB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Patients with inborn errors of immunity (IEI) are predisposed to severe recurrent/chronic infections, and often require hospitalization, resulting in substantial burden to patients/healthcare systems. While immunoglobulin replacement therapies (IgRTs) are the standard first-line treatment for most forms of IEI, limited real-world data exist regarding clinical characteristics and treatment costs for patients with IEI initiating such treatment. This retrospective analysis examined infection and treatment characteristics in US patients with IEI initiating IgRT with immune globulin infusion (human), 10% (IG10%). Healthcare resource utilization (HCRU) and associated costs before and after treatment initiation were compared. Additionally, the impact of COVID-19 on infection diagnoses was evaluated.
Patients with IEI initiating IG10% between July 2012 and August 2019 were selected from Merative MarketScan Databases using diagnosis/prescription codes. Patients were followed 6 months before and after first IG10% claim date. Demographic and clinical characteristics were described. Treatment characteristics and HCRU before and after IG10% initiation were compared. Infection diagnoses during 2020 and 2019 (March–December) were compared.
The study included 1,497 patients with IEI diagnoses (mean age = 43.4 years) initiating IG10%, with frequently reported comorbidities like asthma (32.1%). Following IG10% initiation, fewer severe infection diagnoses (11.6% vs 19.9%), fewer infection-related inpatient (10.8% vs 19.5%) and outpatient services (71.6% vs 79.9%), and lower infection-related total healthcare costs ($7,849 vs $13,995; p Patients with IEI are susceptible to severe infections leading to high disease burden and treatment costs. Following IG10% initiation, we observed fewer infections, lower infection-related treatment costs, and shift in care (inpatient to outpatient) leading to significant cost savings. Among patients with IEI, 27% fewer infection diagnoses were observed during the early COVID-19 lockdown period than the prior year.
Some people are born with inborn errors of immunity, or IEI. This study included 1,497 people with IEI who recently started taking a

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.26049805.v3(source: https://tandf.figshare.com/articles/dataset/Initiating_immunoglobulin_replacement_therapy_helps_reduce_severe_infections_and_shifts_healthcare_resource_utilization_to_outpatient_services_among_US_patients_with_inborn_errors_of_immunity/26049805)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案